CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Gabapentinoids for Chronic Pain in Pediatric Populations: Clinical Effectiveness

Last updated: May 6, 2020
Project Number: RB1479-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of gabapentinoids for the treatment of chronic pain in pediatric patients?

Key Message

Two systematic reviews and three randomized controlled trials were identified regarding the clinical effectiveness of gabapentinoids for the treatment of chronic pain in pediatric patients.